Searched for
RIDGEBACK BIOTHERAPEUTICS
B'luru firm Bugworks begins work on drug against Covid-type virusesThe hunt for safe and effective Covid antivirals that can be used against Covid is on. Currently Pfizer's Paxlovid and MSD-Ridgeback Biothe...- EU regulator set to rule on Pfizer COVID pill by end-Jan, ahead of Merck - sourceThe EMA's review of Merck's pill, developed with Ridgeback Biotherapeutics, is taking longer than Pfizer's because Merck released trial dat...
- Natco Pharma signs pact with MPP to sell Molnupiravir capsulesNatco Pharma has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupi...
- Sun Pharma gets DCGI nod to market molnupiravir for COVID-19 treatmentEarlier this year, the Mumbai-based drug major had signed a non-exclusive voluntary licensing agreement with MSD to manufacture and supply ...
- A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
- U.S. FDA authorizes Merck's at-home antiviral COVID-19 pillMerck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a cl...
- COVID antiviral drug Molnupiravir efficacy against hospitalization or death drops to 30% compared to placebo groupThe analysis of latest data on efficacy is much less than the previous interim analysis announced by the company which was based on data fr...
- Merck's COVID-19 pill shows lower efficacy in updated dataThe drugmaker released interim data in October showing a roughly 50% reduction in hospitalizations and deaths in 775 patients. The updated ...
- Panel to meet today to take up applications seeking nod for MolnupiravirThe firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other...
- With UK nod, Merck drug becomes world's 1st pill for Covid treatmentThe MHRA recommended the use of Covid-19 drug molnupiravir as soon as possible following a positive Covid-19 test and within five days of s...
- UK drug regulatory approves COVID antiviral drug MolnupiravirThe risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease. MHRA recommended the use of Molnupiravir as s...
- PM Modi meets Bill Gates in Glasgow on sidelines of UN conference on climate changeThe meeting between Modi and the American business magnate, whose foundation is focusing on fighting the pandemic, took place after the for...
- Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravirNatco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. "We have submitted p...
- WHO seeks more data from Merck and Bharat BiotechWHO assistant director said that the organisation expects to receive clarifications from Bharat Biotech by the end of this week on its COVI...
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...
- India's Everest Organics starts making ingredient for Merck's COVID-19 pillThe Indian bulk drugs manufacturer joins Divi's Laboratories Ltd as an API maker for Merck's experimental oral drug. Merck has separately e...
- Place bulk orders for Merck's Covid pillThe trials show that the pill halved the chances of hospitalisation in Covid-19 patients with mild or moderate form of the disease.
- Natco seeks emergency nod for Molnupiravir to treat CovidThe development comes close on the heels of findings announced by the researchers that Molnupiravir was found effective for treating the pa...
- Oral Covid treatment yields promising trial data: DrugmakersIn January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, incl...
- Merck leaps into COVID-19 development fray with vaccine, drug dealsIt also announced a partnership with privately-held Ridgeback Biotherapeutics to develop an experimental oral antiviral drug against COVID-...
Load More
